Dali Pharmaceutical Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 92.047 million compared to CNY 103.855 million a year ago. Operating loss was CNY 1.176 million compared to operating Income of CNY 2.203 million a year ago. Net loss was CNY 1.173 million compared to net income of CNY 545,625.5 a year ago. Basic loss per share from continuing operations was CNY 0.0053 compared to basic earnings per share from continuing operations of CNY 0.0025 a year ago.